Active substance
Results for the substance autologous human cartilaginous cells
1 result
About this active substance
Autologous human chondrocytes are used in regenerative therapy for the treatment of articular cartilage injuries. These cells are harvested from the patient's cartilage, cultured in a laboratory to multiply, and then reimplanted into the affected area to stimulate cartilage tissue regeneration.
This therapy is particularly indicated for patients with small to moderate cartilage lesions that do not respond to other conservative treatments. The procedure requires minimally invasive surgery for cell harvesting and reimplantation.
Patients must follow a strict rehabilitation program after the procedure to ensure treatment success. It is important for them to adhere to the doctor's instructions and avoid activities that may place excessive pressure on the treated joint.
Side effects may include pain, inflammation, or stiffness at the treated site. In rare cases, complications such as infections or adverse reactions to materials used in the procedure may occur.
This therapy is particularly indicated for patients with small to moderate cartilage lesions that do not respond to other conservative treatments. The procedure requires minimally invasive surgery for cell harvesting and reimplantation.
Patients must follow a strict rehabilitation program after the procedure to ensure treatment success. It is important for them to adhere to the doctor's instructions and avoid activities that may place excessive pressure on the treated joint.
Side effects may include pain, inflammation, or stiffness at the treated site. In rare cases, complications such as infections or adverse reactions to materials used in the procedure may occur.